Perindopril Erbumine
Product Images NDC 0527-1920

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Perindopril Erbumine (NDC 0527-1920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Perindopril-erbumine-struc-form (Perindopril Erbumine Tablets 1)

Chemical structure diagram of Perindopril Erbumine showing its molecular composition with carbon rings, carboxyl groups, amino groups, and additional side chains detailed in black lines and letters on a white background.*

FDA Label Image

Fig1 (Perindopril Erbumine Tablets 2)

A line graph showing the time to first occurrence of primary endpoint in a study comparing Perindopril Erbumine and placebo. The y-axis represents the proportion of patients experiencing cardiovascular mortality, nonfatal myocardial infarction, or cardiac arrest in percentage. The x-axis shows time in years, up to 5 years. Two lines depict the proportion for placebo (higher) and Perindopril (lower), with error bars at intervals. A table below lists numbers of patients at risk over time for both groups.*

FDA Label Image

Fig2 (Perindopril Erbumine Tablets 3)

A forest plot chart titled 'Beneficial Effect of Perindopril Treatment on Primary Endpoint in Predefined Subgroups' showing primary event percentages for perindopril versus placebo across multiple patient subgroups by gender, age, clinical history, and concomitant drug use. The chart includes the number of patients per group, percentages of primary events for perindopril and placebo, and a relative risk plot indicating treatment favorability. Square sizes correspond to subgroup patient numbers.*

FDA Label Image

4mg-container-label (Perindopril Erbumine Tablets 4)

Label for Perindopril Erbumine Tablets, 4 mg, showing a 100-tablet package. The label includes the active ingredient strength, directions to see accompanying literature for dosage and administration, storage instructions, and manufacturer details (Patheon Pharmaceuticals, Inc.). Marketed by Lannett Company, Inc., with a barcode and lot/expiration fields. The product is identified as a product of France.*

FDA Label Image

8mg-container-label (Perindopril Erbumine Tablets 5)

Label for Perindopril Erbumine Tablets 8 mg, containing 100 tablets. The label states it is prescription only and advises keeping out of reach of children. Manufactured by Patheon Pharmaceuticals, Inc., Cincinnati, OH, and marketed by Lannett Company, Inc., Philadelphia, PA. The product is from France and includes storage directions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.